Form 11-K - Annual report of employee stock purchase, savings and similar plans:
SEC Accession No. 0000310158-26-000194
Filing Date
2026-06-24
Accepted
2026-06-24 15:08:47
Documents
35
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 11-K mrk-20260624.htm   iXBRL 11-K 303105
2 EX-23 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ye2025merckussavingsplan_e.htm EX-23 2208
8 mrk-20260624_g1.jpg GRAPHIC 3611
  Complete submission text file 0000310158-26-000194.txt   2184295

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrk-20260624.xsd EX-101.SCH 15832
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrk-20260624_cal.xml EX-101.CAL 21269
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrk-20260624_def.xml EX-101.DEF 156308
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrk-20260624_lab.xml EX-101.LAB 187472
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrk-20260624_pre.xml EX-101.PRE 166713
41 EXTRACTED XBRL INSTANCE DOCUMENT mrk-20260624_htm.xml XML 342650
Mailing Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065
Business Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 11-K | Act: 34 | File No.: 001-06571 | Film No.: 261115507
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)